159
Views
3
CrossRef citations to date
0
Altmetric
Review

The role of desmosines as biomarkers for chronic obstructive pulmonary disease

&
Pages 137-144 | Published online: 09 Jan 2014

References

  • Agustí A, Vestbo J. Current controversies and future perspectives in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 184(5), 507–513 (2011).
  • Cazzola M, MacNee W, Martinez FJ et al.; American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur. Respir. J. 31(2), 416–469 (2008).
  • De Gruttola VG, Clax P, DeMets DL et al. Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a National Institutes of Health workshop. Control. Clin. Trials 22(5), 485–502 (2001).
  • Barnes PJ, Chowdhury B, Kharitonov SA et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 174(1), 6–14 (2006).
  • Viglio S, Annovazzi L, Luisetti M, Stolk J, Casado B, Iadarola P. Progress in the methodological strategies for the detection in real samples of desmosine and isodesmosine, two biological markers of elastin degradation. J. Sep. Sci. 30(2), 202–213 (2007).
  • Luisetti M, Ma S, Iadarola P et al. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur. Respir. J. 32(5), 1146–1157 (2008).
  • Turino GM, Ma S, Lin YY, Cantor JO, Luisetti M. Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 184(6), 637–641 (2011).
  • Luisetti M, Stolk J, Iadarola P. Desmosine, a biomarker for COPD: old and in the way. Eur. Respir. J. 39(4), 797–798 (2012).
  • Casado B, Iadarola P, Luisetti M, Kussmann M. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers. Expert Rev. Proteomics 5(5), 693–704 (2008).
  • Lindberg CA, Engström G, de Verdier MG et al. Total desmosines in plasma and urine correlate with lung function. Eur. Respir. J. 39(4), 839–845 (2012).
  • Huang JT, Chaudhuri R, Albarbarawi O et al. Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease. Thorax 67(6), 502–508 (2012).
  • Turino GM, Lin YY, He J, Cantor JO, Ma S. Elastin degradation: an effective biomarker in COPD. COPD 9(4), 435–438 (2012).
  • Ma S, Turino GM, Lin YY. Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(21), 1893–1898 (2011).
  • Slowik N, Ma S, He J et al. The effect of secondhand smoke exposure on markers of elastin degradation. Chest 140(4), 946–953 (2011).
  • Fregonese L, Ferrari F, Fumagalli M, Luisetti M, Stolk J, Iadarola P. Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD. COPD 8(5), 329–333 (2011).
  • Albarbarawi O, Barton A, Lin Z et al. Measurement of urinary total desmosine and isodesmosine using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal. Chem. 82(9), 3745–3750 (2010).
  • Annovazzi L, Viglio S, Perani E et al. Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. Electrophoresis 25(4–5), 683–691 (2004).
  • Ferrari F, Fumagalli M, Piccinini P et al. Micellar electrokinetic chromatography with laser induced detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with chronic obstructive pulmonary disease: a comparative analysis. J. Chromatogr. A 1266, 103–109 (2012).
  • Cumiskey WR, Pagani ED, Bode DC. Enrichment and analysis of desmosine and isodesmosine in biological fluids. J. Chromatogr. B, Biomed. Appl. 668(2), 199–207 (1995).
  • Viglio S, Zanaboni G, Luisetti M et al. Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease. J. Chromatogr. B Biomed. Sci. Appl. 714(1), 87–98 (1998).
  • Boutin M, Berthelette C, Gervais FG et al. High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine. Anal. Chem. 81(5), 1881–1887 (2009).
  • Ma S, Lieberman S, Turino GM, Lin YY. The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum. Proc. Natl Acad. Sci. USA 100(22), 12941–12943 (2003).
  • Viglio S, Iadarola P, Lupi A et al. MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur. Respir. J. 15(6), 1039–1045 (2000).
  • Boschetto P, Quintavalle S, Zeni E et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 61(12), 1037–1042 (2006).
  • Lonky SA, Gochman N, Smith S, Bergeron-Lynn G, Jacobs K. Amino acid analysis of elastin hydrolysates using a lithium citrate gradient: quantification of elastin from whole lung. Clin. Chim. Acta 110(2–3), 227–233 (1981).
  • Velebný V, Kasafírek E, Kanta J. Desmosine and isodesmosine contents and elastase activity in normal and cirrhotic rat liver. Biochem. J. 214(3), 1023–1025 (1983).
  • Zarkadas CG, Zarkadas GC, Karatzas CN, Khalili AD, Nguyen Q. Rapid method for determining desmosine, isodesmosine, 5-hydroxylysine, tryptophan, lysinoalanine and the amino sugars in proteins and tissues. J. Chromatogr. 378(1), 67–76 (1986).
  • Bruce MC, Wedig KE, Jentoft N et al. Altered urinary excretion of elastin cross-links in premature infants who develop bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 131(4), 568–572 (1985).
  • Bruce MC, Poncz L, Klinger JD, Stern RC, Tomashefski JF Jr, Dearborn DG. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am. Rev. Respir. Dis. 132(3), 529–535 (1985).
  • Starcher BC. Antibodies to desmosine. Meth. Enzymol. 82(Part A), 759–762 (1982).
  • King GS, Mohan VS, Starcher BC. Radioimmunoassay for desmosine. Connect. Tissue Res. 7(4), 263–267 (1980).
  • Starcher BC, Mecham RP. Desmosine radioimmunoassay as a means of studying elastogenesis in cell culture. Connect. Tissue Res. 8(3–4), 255–258 (1981).
  • Gunja-Smith Z. An enzyme-linked immunosorbent assay to quantitate the elastin crosslink desmosine in tissue and urine samples. Anal. Biochem. 147(1), 258–264 (1985).
  • Verplanke AJ, Watanabe T, Ishimori K, Matsuki H, Kasuga H. Experience with an enzyme-linked immuno sorbent assay for the quantitation of urinary desmosine. Tokai J. Exp. Clin. Med. 13(3), 159–163 (1988).
  • Matsumoto T, Mizusaki S, Nishimura K, Oshima S. An enzyme-linked immunosorbent assay for desmosine. Bull. Chest Dis. Res. Inst. Kyoto Univ. 19(1–2), 9–22 (1986).
  • Cocci F, Miniati M, Monti S et al. Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease. Int. J. Biochem. Cell Biol. 34(6), 594–604 (2002).
  • Harel S, Janoff A, Yu SY, Hurewitz A, Bergofsky EH. Desmosine radioimmunoassay for measuring elastin degradation in vivo. Am. Rev. Respir. Dis. 122(5), 769–773 (1980).
  • Stone PJ, Bryan-Rhadfi J, Lucey EC et al. Measurement of urinary desmosine by isotope dilution and high performance liquid chromatography. Correlation between elastase-induced air-space enlargement in the hamster and elevation of urinary desmosine. Am. Rev. Respir. Dis. 144(2), 284–290 (1991).
  • Stone PJ, Lucey EC, Snider GL, Franzblau C. Effect of diet on urinary excretion of desmosine and hydroxylysyl pyridinoline. Am. J. Respir. Crit. Care Med. 149(1), 174–177 (1994).
  • Gottlieb DJ, Stone PJ, Sparrow D et al. Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. Am. J. Respir. Crit. Care Med. 154(5), 1290–1295 (1996).
  • Stone PJ, Gottlieb DJ, O’Connor GT et al. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 151(4), 952–959 (1995).
  • Stone PJ, Konstan MW, Berger M, Dorkin HL, Franzblau C, Snider GL. Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 152(1), 157–162 (1995).
  • MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2(4), 258–266; discussion 290 (2005).
  • Vestbo J, Anderson W, Coxson HO et al.; ECLIPSE investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur. Respir. J. 31(4), 869–873 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.